March 2013 FDA Recall Drug by Reckitt Benckiser Inc
D-310-2013 - Subpotent Drug

This Class III drug recall was voluntarily initiated by Reckitt Benckiser Inc on March 18, 2013 for the product Drug. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-310-2013

Reason for Recall
Subpotent Drug: Product did not conform to the 18-month stability test specification for active Free Benzocaine.
Initiated
03-18-2013
Reported
05-08-2013
Quantity
27,718 cases 16 count and 7,551 cases 576 count

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Reckitt Benckiser Inc
Cherry Cepacol Sore Throat Lozenges, Benzocaine 15 mg | Menthol 3.6 mg, a)16-count, NDC 63824-711-16 b) Institutional Size, 576-count, NDC 63824-711-98, OTC, Dist. by: Reckitt Benckiser, Parsippany, NJ 07054

Batch or Lot Expiration Information

Lot# 16 count: AG156 Exp 11/13, AG257 Exp 12/13, AH388 02/14, AJ167 03/14, AL367 Exp 05/14, AL555 & AL568 Exp 06/14, AM141 Exp 07/14. 576 Count: AK505 Exp 04/14, AK570 Exp 05/14, AH368 & AH398 Exp 02/14, AJ000 Exp 03/14, AG596 Exp 12/13